Akebia Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AKBA Nasdaq 2836 www.akebia.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akebia Therapeutics, Inc.

Akebia announces ‘multiple positive business updates’ - Jan 14th, 2025 1:28 pm
Akebia Therapeutics Announces Multiple Positive Business Updates - Jan 13th, 2025 1:00 pm
New Strong Sell Stocks for January 3rd - Jan 3rd, 2025 9:52 am
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 2nd, 2025 9:05 pm
High Growth Tech Stocks To Watch In December 2024 - Dec 20th, 2024 6:02 pm
Investors in Akebia Therapeutics (NASDAQ:AKBA) have unfortunately lost 73% over the last five years - Dec 20th, 2024 12:27 pm
Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Dec 18th, 2024 1:00 pm
New Strong Sell Stocks for December 5th - Dec 5th, 2024 10:46 am
U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis - Dec 3rd, 2024 12:00 pm
New Strong Sell Stocks for November 27th - Nov 27th, 2024 9:42 am
Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference - Nov 25th, 2024 1:00 pm
Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease - Nov 14th, 2024 1:00 pm
Akebia Therapeutics to Present at the Jefferies London Healthcare Conference - Nov 12th, 2024 1:00 pm
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50 - Nov 9th, 2024 1:33 pm
Akebia Therapeutics Inc (AKBA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... - Nov 8th, 2024 7:09 am
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Nov 7th, 2024 1:15 pm
Akebia Therapeutics: Q3 Earnings Snapshot - Nov 7th, 2024 12:21 pm
Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Nov 7th, 2024 12:00 pm
Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business Highlights - Nov 1st, 2024 12:00 pm
High Growth Tech Stocks to Watch in October 2024 - Oct 23rd, 2024 2:02 pm